---
title: "Indian drug manufacturer Neuland Labs slumps on Q3 results"
date: "2025-02-11 12:16:52"
summary: "** India's Neuland Laboratories down 6.04% at 13,782 rupees after Q3 results** Stock set for worst day since Nov. 6 when it reported Q2 results** Bulk drug manufacturer's Q3 core profit declines by 26.4% y/y, while revenue increases less than 2%** Stock has more than doubled in value in the..."
categories:
  - "Reuters"
lang:
  - "en"
translations:
  - "en"
tags:
  - "Reuters"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

\*\* India's Neuland Laboratories down 6.04% at 13,782 rupees after Q3 results

\*\* Stock set for worst day since Nov. 6 when it reported Q2 results

\*\* Bulk drug manufacturer's Q3 core profit declines by 26.4% y/y, while revenue increases less than 2%

\*\* Stock has more than doubled in value in the last 12 months

[Reuters](https://www.tradingview.com/news/reuters.com,2025:newsml_L4N3P209A:0-indian-drug-manufacturer-neuland-labs-slumps-on-q3-results/)
